T-Mobile US (NasdaqGS:TMUS) Partners With IPG Mediabrands For Enhanced Advertising Solutions
Last week, T-Mobile US announced a major partnership with IPG Mediabrands, which allows the latter's agencies and clients to tap into T-Mobile's first-party data for enhanced advertising solutions. This development is thought to have positively influenced T-Mobile's stock, as the company's share price increased by 2.78% over the period, aligning with the market's broader 2.2% rise. While the market navigated uncertainties related to tariffs and upcoming Federal Reserve decisions, T-Mobile's move potentially added momentum to its stock in line with the general upward market trend.
We've discovered 2 risks for T-Mobile US that you should be aware of before investing here.
NasdaqGS:TMUS Revenue & Expenses Breakdown as at May 2025
The end of cancer? These 23 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
The recent partnership between T-Mobile US and IPG Mediabrands underscores T-Mobile's potential to leverage its extensive 5G and data resources to bolster advertising solutions. This initiative aligns with T-Mobile's ongoing 5G and T-Fiber expansions, which are highlighted in its growth narrative. As T-Mobile continues to enhance its postpaid and broadband offerings, this strategic collaboration could support both revenue and margin improvements, reflecting positively in future earnings forecasts.
Over the past five years, T-Mobile's total shareholder return, encompassing share price appreciation and dividends, was 168.87%. This robust growth suggests that the company's strategic moves, including its recent partnership, may contribute positively to long-term shareholder gains. Comparing T-Mobile's one-year return, which matched the 53.9% seen by the US Wireless Telecom industry, highlights its competitive standing within the sector.
The recent share price increase of 2.78% brings T-Mobile closer to analysts' consensus price target of US$266.22, which remains approximately 9.3% above the current price of US$241.59. This proximity to the target price scenario reflects market optimism towards T-Mobile's growth prospects and strategic initiatives, although the full realization of forecasted revenue and earnings growth will be critical to closing this gap.
Learn about T-Mobile US' future growth trajectory here.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
T-Mobile is rolling out satellite coverage to its plans soon – and you can already try it out for free even if you're at another carrier
When you buy through links on our articles, Future and its syndication partners may earn a commission. T-Mobile is introducing satellite coverage to its plans in July The T-Satellite service is now in beta and free to try Most modern phones are compatible T-Mobile has launched a nationwide beta for its new satellite phone service, allowing users to stay connected in areas without traditional cell coverage. Called T-Satellite, the feature connects automatically when you're out of range of cellular networks, enabling basic connectivity in remote locations. The beta is currently free to join and open to anyone, regardless of carrier, through the end of July. During the beta, users will be able to send and receive texts, make calls, and access data via satellite. You can sign up for the beta now by providing an email address with no special hardware required - according to the T&C's, most modern smartphones will be eligible. T-Mobile is planning on rolling out the T-Satellite service at no extra cost with the carrier's high-end Experience Beyond and Go5G Next plans at some point in July this year. Customers who opt into the Experience More plan now will receive satellite coverage for free through the end of the year. Interestingly, the carrier's T-Satellite service will also be available to customers on other networks, including both Verizon and AT&T. While the initial beta period is free to all, the service will be available at an introductory price of $10 per month. According to the FAQ, that will equate to a $5/mo saving in total. Note, as of writing, the carrier has not confirmed how long the introductory pricing will be available. What is Starlink? How to get the satellite service for free on your phone No, iOS 18.3 doesn't install Starlink on your iPhone The best T-Mobile deals for June 2025
Business Wire
3 hours ago
- Business Wire
Tempus Announces Collaboration with Northwestern University's Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer's Disease Research
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with The Abrams Research Center on Neurogenomics at Northwestern University Feinberg School of Medicine. This multi-year collaboration aims to harness AI for rapid discovery and innovation in Alzheimer's disease research. The collaboration leverages Tempus' AI-powered data analytics platform, Lens, to analyze and restructure the Center's repository of genomic data. Together, the Center and Tempus teams will work to uncover genomic patterns that have the potential to advance the understanding of Alzheimer's disease, investigate the gene and cell types affected, enable the development of new therapeutics, and accelerate the creation of novel clinical applications. By harnessing Lens' advanced AI capabilities, the collaboration aims to generate actionable insights that drive the discovery of targeted therapies and significantly improve patient outcomes. 'We are excited to collaborate with the Abrams Research Center on Neurogenomics to confront one of the most complex and pressing medical challenges of our time,' said Ryan Fukushima, Chief Operating Officer at Tempus. 'By integrating our AI platform with the Center's pioneering work in neurogenomics, we are opening new avenues for discovery. Together, we strive to advance research for Alzheimer's and bring hope and tangible impact to patients and families affected by this devastating disease.' 'This collaboration with Tempus represents an important step forward in our mission to harness cutting-edge technologies to transform Alzheimer's research,' said David Gate, PhD, assistant professor in Ken and Ruth Davee Department of Neurology at Feinberg and head of The Abrams Research Center on Neurogenomics. 'We share a commitment to deepen our understanding of the genomic underpinnings of Alzheimer's disease and accelerate the development of more targeted, effective interventions.' About Tempus Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world's largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the 'Securities Act'), and Section 21E of the Securities Exchange Act of 1934, as amended, about Tempus and Tempus' industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding the expected outcomes and benefits of the collaboration with the Abrams Research Center on Neurogenomics to advance research for Alzheimer's disease are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as 'anticipate,' 'believe,' 'contemplate,' 'continue,' 'could,' 'estimate,' 'expect,' 'going to,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' or 'would' or the negative of these words or other similar terms or expressions. Tempus cautions you that the foregoing may not include all of the forward-looking statements made in this press release. You should not rely on forward-looking statements as predictions of future events. Tempus has based the forward-looking statements contained in this press release primarily on its current expectations and projections about future events and trends that it believes may affect Tempus' business, financial condition, results of operations and prospects. These forward-looking statements are subject to risks and uncertainties related to: the intended use of Tempus' products and services; Tempus' financial performance; the ability to attract and retain customers and partners; managing Tempus' growth and future expenses; competition and new market entrants; compliance with new laws, regulations and executive actions, including any evolving regulations in the artificial intelligence space; the ability to maintain, protect and enhance Tempus' intellectual property; the ability to attract and retain qualified team members and key personnel; the ability to repay or refinance outstanding debt, or to access additional financing; future acquisitions, divestitures or investments; the potential adverse impact of climate change, natural disasters, health epidemics, macroeconomic conditions, and war or other armed conflict, as well as risks, uncertainties, and other factors described in the section titled 'Risk Factors' in Tempus' Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission ('SEC') on February 24, 2025, as well as in other filings Tempus may make with the SEC in the future. In addition, any forward-looking statements contained in this press release are based on assumptions that Tempus believes to be reasonable as of this date. Tempus undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.
Yahoo
4 hours ago
- Yahoo
Latest News In Energy Transition - CleanChoice Energy Expands Renewable Portfolio With New Solar Projects
CleanChoice Energy is broadening its renewable energy portfolio with the acquisition of two solar projects in New York State, aimed at generating a combined 54.2 MW of clean electricity. These projects, situated in Washington and Rensselaer Counties, were selected by the New York State Energy Research and Development Authority as part of efforts to meet the state's goal of 70% clean electricity by 2030. This expansion marks a significant stride in CleanChoice's strategy to bolster its solar generation capacity and strengthen community connections to locally-produced clean energy. As national and regional electricity grids face rising demand and consumer interest in sustainable energy solutions, initiatives like these underscore the ongoing transition towards renewable energy sources. In other trading, was a notable mover up 11% and ending the day at $49.79. At the same time, lagged, down 6.1% to end the day at $117.13. On Tuesday, the company declared a regular quarterly cash dividend of $0.55 per share. Fluor Corporation's strategic shift towards high-growth markets may lead to net margin improvements. Explore Fluor's transformative strategy and its potential impact on earnings here. Don't miss the Market Insights article "Opportunities In The Turbulent Transition To Greener Energy," which explores current renewable stock struggles and emerging nuclear options; read it now before market shifts. finished trading at $167.86 up 2%. settled at $144.78 up 1%. settled at $326.43 up 0.1%. Click through to start exploring the rest of the 153 Energy Transition Stocks including Jiangsu Financial Leasing, Dubai Electricity and Water Authority (PJSC) and Hindustan Zinc now. Interested In Other Possibilities? These 18 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sources: Simply Wall St "CleanChoice Energy Expands Footprint with its First Two Solar Projects in New York State" from CleanChoice Energy on GlobeNewswire (published 11 June 2025) Companies discussed in this article include NYSE:FLR NasdaqGS:FSLR NYSE:CVX NasdaqGS:TSLA and NYSE:NUE. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
